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Abstract
The mechanisms regulating late-gestational and early postnatal semilunar valve
remodeling and maturation are poorly understood. Tie1 is a receptor tyrosine
kinase with broad expression in embryonic endothelium. During semilunar valve
development, Tie1 expression becomes restricted to the turbulent, arterial
surfaces of the valves in the perinatal period. Previous studies in our laboratory
have demonstrated that Tie1 can regulate cellular responses to blood flow and
shear stress. We hypothesized that Tie1 signaling would regulate the flow-
dependent remodeling of the semilunar valves associated with the conversion
from maternal/placental to independent neonatal circulation. To circumvent the
embryonic lethality of the Tie1 null mutation, we developed a floxed Tie1 allele
and crossed it with an Nfactc1enCre line that mediates gene excision exclusively
in the endocardial cushion endothelium. Excision of Tie1 resulted in aortic valve
leaflets displaying hypertrophy with perturbed matrix deposition. The valves
demonstrated insufficiency and stenosis by ultrasound, and atomic force micros-
copy documented decreased stiffness in the mutant aortic valve consistent with
an increased glycosaminoglycan to collagen ratio. These data suggest that active
endocardial to mesenchymal signaling, at least partially mediated by Tie1, is
uniquely required for normal remodeling of the aortic but not pulmonary valve
in the late gestation and postnatal animal.
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19.1 Introduction
Cardiovascular defects are the most common congenital abnormality in the human
population, affecting approximately 1 out of every 100 live births worldwide
[1]. Defects in valve development account for 25–30 % of these malformations.
Therefore, there is significant interest in understanding the mechanisms that under-
lie the complex process of heart valve development. During heart valve formation,
a subset of endothelial cells overlying the future valve site are specified to delami-
nate, differentiate, and migrate into the cardiac jelly, a process referred to as
endothelial-mesenchymal transformation or transdifferentiation (EMT). Locally
expanded swellings of cardiac jelly and mesenchymal cells are referred to as
cardiac cushions. In a poorly understood process, these cardiac cushions undergo
extensive remodeling from bulbous swellings to eventual thinly tapered heart valve
leaflets [2]. Numerous studies have focused on identifying the major regulators of
valve development using murine and avian embryos and have particularly focused
on the early stages of valve development; however, the pathways regulating the
final events of remodeling and maturation have not been well defined.
The orphan receptor tyrosine kinase Tie1 is primarily expressed in endothelial
cells and is closely related to Tie2, the receptor for the angiopoietins. Both Tie1 and
Tie2 are essential for developmental vascularization where they appear to have
roles in promoting microvessel maturation and stability. Targeted disruption of
Tie1 gene in mice results in a lethal phenotype between E14.5 and P0 characterized
by extensive edema, hemorrhage, and defective microvessel integrity [3–5]. Expres-
sion of Tie1 is first detected in the endothelium of mice at E8.0, and by E12.5, Tie1
is robustly expressed in the valvular endothelium, vasculature, heart, and lungs [6–
9]. Tie1 expression subsides in the postnatal period, although low levels of Tie1
persist into adulthood on the arterial side of the valve leaflet as well as branch points
of the descending aorta [10]. Thus, Tie1 is expressed in the vasculature, valves, and
other endothelial cell populations in the developing heart during critical periods of
valve morphogenesis. However, its potential roles in heart valve development are
totally unknown. Here, using a conditional knockout mouse model, we show that
lack of Tie1 in endocardial cells leads to hypertrophic semilunar valves in the
postnatal and adult heart.
19.2 Model for Valvar Endocardial-Specific Gene Deletion
To specifically determine the potential role of Tie1 in valve morphogenesis, we
have developed a novel valve endocardial cell-specific Cre mouse line
(Nfatc1enCre). We previously identified a transcriptional enhancer that regulates
the sustained expression of Nfatc1 exclusively in the endocardium overlying the
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endocardial cushions [11]. We then utilized this enhancer to develop a transgenic
mouse line, Nfactc1enCre, which has recently been described by our lab [12]. To
determine the utility and efficiency of this model for deletion at latter stages of
cardiac development, we have analyzed Cre expression in the developing valves by
lacZ staining and qRT-PCR of Nfactc1enCre transgenic mice bred with R26R
reporter mice (Fig. 19.1a–d). lacZ staining confirmed that Cre activation is first
detected at E9.5 in the developing AVC region and in OFT region by E10.5 (data
not shown). Cre activation is localized to endocardial cushion endocardium of the
outflow track at E12.5 and at E14.5 (Fig. 19.1a, b) and remains restricted to the
endocardium of overlying the developing valves throughout gestation into the
perinatal period (Fig. 19.1c) and in the adult (data not shown). To determine the
utility of Nfactc1enCre for tissue-specific deletion, we crossed these mice with our
mice harboring a floxed Tie1 allele previously described [5]. When Tie1 expression
as determined by QT-PCR was normalized to expression detected in the adult
animal, we observed the normal attenuation of Tie1 previously described by our
group [5]. In addition we observed significant attenuation of Tie1 expression as a
result of Cre-mediated deletion in the heart that was not detected in other vascular
beds (data not shown). Thus our Cre transgenic line Nfactc1enCre mediates loxP
excision exclusively in the endocardium overlying the endocardial cushions and not
in mesenchyme derived from EMT or other endothelial populations.
19.3 Tie1 Is Required for Late-Gestational and Early Postnatal
Aortic Valve Remodeling
To investigate the potential role of Tie1 in valve morphogenesis, we generated
endocardial-specific Tie1 knockout (Tie1fl/lz;Nfactc1enCre) mice by breeding mice
homozygous for a floxed Tie1 allele [5] with mice heterozygous for a null mutation
in Tie1fl/lz (Tie1þ/lz is a “knock-in”/knockout” insertion of lacZ into the Tie 1 locus
[3]) as well as the Nfactc1enCre transgene. Analysis of timed matings revealed that
no embryos died in utero during early gestation. However, within a few days after
birth, Tie1fl/lz;Nfactc1enCre pups could be distinguished from Tie1fl/fl or Tie1fl/lz
littermates as the mutants were often growth retarded (Fig. 19.2) and lethargic, both
of which are characteristics of human patients with heart defects. Most of mutants
did not survive to adulthood. Histological analysis revealed no significant
differences in valve formation between mutants and littermates until E16.5
(Fig. 19.3a, b), indicating early events of valvulogenesis occur normally in Tie1
mutant mice. However, an increase in semilunar valve size was noted in Tie1fl/lz;
Nfactc1enCre mice from E18.5 (Fig. 19.3c, d) and early perinatal periods with the
discrepancy in valve size continuing into the adult (Fig. 19.3e, f). Interestingly, the
valve abnormalities were not only limited to the late gestation and postnatal period,
but they were also primarily only detected in the aortic valves. The aortic valve
areas of adult Tie1fl/lz;Nfactc1enCremice were nearly twice as large as Tie1fl/fl aortic
valves (increased by 88.3 %). The pulmonary valves of Tie1fl/lz;Nfactc1enCre mice
were somewhat thicker than the controls, but the difference was not significant.
There were no differences in cell proliferation or apoptosis between mutant mice













Fig. 19.1 Nfactc1enCre mediates loxP excision exclusively in the valvular endocardium. (a)
Schematic of breeding of Nfatc1enCre and R26fslz mice. X-gal staining of R26fslz;Nfactc1enCre
heart sections shows that expression of the Cre is restricted to the endothelium of the developing
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and littermates suggesting a difference in extracellular matrix (ECM) composition
or production. Consistent with this, Movat’s pentachrome stain revealed an increase
in proteoglycan/glycosaminoglycan (GAGs) production and/or degradation in the
valve interstitium of postnatal Tie1fl/lz;Nfactc1enCre mice. As compared to Tie1fl/fl,
GAGs content (Fig. 19.3e, f) was increased and total collagen content (data not
shown) was decreased in aortic valve leaflets of Tie1fl/lz;Nfactc1enCre animals.
Thus, attenuation of Tie1 results in severe abnormalities in ECM remodeling that
are characteristic of critical events in late gestation and postnatal valve develop-
ment in chicken, mouse, and humans [13, 14]. This work suggests that there is a
non-cell autonomous defect that results from endocardial-specific Tie1 deletion as
the ECM is produced primarily from the valvular interstitial cells (VICS), not the
endocardium. This work also provides in vivo support for the in vitro observations
that valvular endocardial cells regulate the phenotype of VICS. In addition, Tie1
mutant aortic valves demonstrated a decrease in rigidity as measured by atomic
force microscopy and valvular insufficiency, as determined by high-resolution
ultrasound (data not shown).
19.4 Future Directions
This study describes a unique dosage-dependant role for Tie1 during later stages of
valve remodeling. Tie1 is essential for valve remodeling, and abnormalities within
late-gestational valve remodeling lead to flaccid valve leaflets, which in turn do not
function correctly in the animal. It is likely that the mortality observed in Tie1fl/lz;
Nfactc1enCre mice can be attributed to aortic insufficiency and ultimate heart
failure. However, the mechanisms regulating late-gestational and early postnatal
semilunar valve remodeling and maturation are still poorly understood.

Fig. 19.1 (continued) valves (arrowhead) at E14.5 (b, c) and at P0 (d), and weak lacZ expression
remains in the majority of the valvular endothelial cells through adulthood (d). HSP68 indicates





smaller than the controls
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Tie1, although a close sequence homologue of Tie2, does not interact directly
with the angiopoietins, and its in vivo ligands are yet to be identified. Nevertheless,
growing reports based on in vitro studies suggest that a primary function of Tie1
might be to modulate Tie2 signaling and function [15–17]. Furthermore, both Tie1
and Tie2 are co-expressed in endocardial cells from very early endocardial cushion
stage to the mature valve stage. So, we hypothesize that Tie1 signals independent of
Tie2 and also acts an inhibitory co-receptor for Tie2 activation. Further investiga-
tion on this project using double (Tie1 and Tie2) conditional knockouts is currently
on the way. Additional animal models are being developed to characterize the
mechanism of Tie1-Tie2 interactions in modulating critical events in cardiac
ontogeny in vivo, and expression profiling is being implemented to delineate
A








Fig. 19.3 Tie1 attenuation leads to enlarged aortic valves and abnormal ECM deposition and
organization. H&E-stained sections of valves of Tie1fl/fl and Tie1fl/lz;Nfactc1enCre mice at E16.5
(a, b) and at E18.5 (c, d). Compared to Tie1fl/fl mice, Tie1fl/lz;Nfactc1enCre mice have enlarged
aortic valves. Movat’s pentachrome stain shows enlarged aortic valves with increased GAGs
deposition (blue) in adult (9 weeks) Tie1fl/lz;Nfactc1enCre mice (f) as compared to the controls (e).
Arrows indicate valve leaflets. Scale bars: 50 μm
158 X. Qu and H.S. Baldwin
downstream signaling cascades that are activated by Tie1 and Tie1-Tie2
interactions. These studies will be essential for understanding the role of the
endocardium in modulation valve matrix deposition and remodeling in an effort
to unravel basic mechanisms of congenital heart disease.
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